Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma

European Urology

Volumn 51, Issue 2, 2007, Pages 409-415

  Marín Aguilera, Mercedes ^a,b   Mengual, Lourdes ^a,b   Ribal, María José ^a   Musquera, Mireia ^a   Ars, Elisabet ^b   Villavicencio, Humberto ^b   Algaba, Ferran ^b   Alcaraz, Antonio ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Carcinoma; Fluorescence; In situ hybridization; Pelvic neoplasms; Transitional cell; Ureteral neoplasms; Urinary tract; Urine

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME ABERRATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY TRACT; URINARY TRACT CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URETERAL NEOPLASMS;

EID: 33845578149     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.08.045     Document Type: Article

References (25)

1. Steffens J., and Nagel R. Tumours of the renal pelvis and ureter. Observations in 170 patients. Br J Urol 61 (1988) 277-283
2. Kirkali Z., and Tuzel E. Transitional cell carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol 47 (2003) 155-169
3. Mills I.W., Laniado M.E., and Patel A. The role of endoscopy in the management of patients with upper urinary tract transitional cell carcinoma. BJU Int 87 (2001) 150-162
4. Wiener H.G., Mian C., Haitel A., Pycha A., Schatzl G., and Marberger M. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?. J Urol 159 (1998) 1876-1880
5. Sokolova I.A., Halling K.C., Jenkins R.B., et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2 (2000) 116-123
6. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768-1775
7. Halling K.C., King W., Sokolova I.A., et al. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine. J Urol 167 (2002) 2001-2006
8. Bubendorf L., Grilli B., Sauter G., Mihatsch M.J., Gasser T.C., and Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116 (2001) 79-86
9. Sarosdy M.F., Schellhammer P., Bokinsky G., et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168 (2002) 1950-1954
10. Placer J., Espinet B., Salido M., Solé F., and Gelabert-Mas A. Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology. Eur Urol 42 (2002) 547-552
11. Skacel M., Fahmy M., Brainard J.A., et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169 (2003) 2101-2105
12. Fadl-Elmula I., Gorunova L., Mandahl N., et al. Cytogenetic analysis of upper urinary tract transitional cell carcinomas. Cancer Genet Cytogenet 115 (1999) 123-127
13. Lopez-Beltran A, Sauter G, Gasser T, et al. World Health Organization. Classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004.
14. Sobin L., and Wittekind C.H. Urological tumours: bladder TNM Classification of Malignant Tumours. 6th ed. (2002), John Wiley & Sons, New York
15. Stewart G.D., Bariol S.V., Grigor K.M., Tolley D.A., and McNeill S.A. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int 95 (2005) 791-793
16. Oosterlinck W., Solsona E., van der Meijden A.P., et al. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46 (2004) 147-154
17. Chow N.H., Tzai T.S., Cheng H.L., Chan S.H., and Lin J.S. Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test?. Urol Int 53 (1994) 18-23
18. Lodde M., Mian C., Wiener H., Haitel A., Pycha A., and Marberger M. Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report. Urology 58 (2001) 362-366
19. Potts S.A., Thomas P.A., Cohen M.B., and Raab S.S. Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract. Mod Pathol 10 (1997) 657-662
20. Bastacky S., Ibrahim S., Wilczynski S.P., and Murphy W.M. The accuracy of urinary cytology in daily practice. Cancer 87 (1999) 118-128
21. van Rhijn B.W., van der Poel H.G., and van der Kwast T.H. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47 (2005) 736-748
22. Halling K.C. Vysis UroVysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn 3 (2003) 507-519
23. Varella-Garcia M., Akduman B., Sunpaweravong P., Di Maria M.V., and Crawford E.D. The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer. Urol Oncol 22 (2004) 16-19
24. Iborra I., Solsona E., Casanova J., Ricos J.V., Rubio J., and Climent M.A. Conservative elective treatment of upper urinary tract tumours: a multivariate analysis of prognostic factors for recurrence and progression. J Urol 169 (2003) 82-85
25. Jewett M.A. Upper tract urothelial carcinoma. J Urol 175 (2006) 12-13